Bitget App
Aqlliroq savdo qiling
Kripto sotib olishBozorlarSavdoFyuchersEarnKvadratKo'proq

HCAT stock price forecast

How will HCAT stock perform in 2026 and 2030?

This page primarily displays the projected price range for HCAT stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of HCAT, the development trends of Health Catalyst, Inc, and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for HCAT. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Health Catalyst, Inc's financial performance and industry trends to provide short-term price predictions for HCAT stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year HCAT stock price forecast

Price target:
4.72 USD
+156.52%
Based on 1-year price forecasts from 48 analysts, the highest estimate is 6.81 USD, while the lowest estimate is 2.28 USD.

Analyst rating for HCAT

Based on ratings from 24 analysts over the past three months, the overall consensus is Buy.

Strong buy
17
Buy
2
Hold
1
Sell
3
Strong sell
1

Tez-tez beriladigan savollar

How has HCAT's EPS performed recently?

HCAT's EPS is projected to reach 0.090 USD next quarter. Explore more Health Catalyst, Inc financial data and stay up to date on the company's latest developments on the HCAT stock details page.

What is the revenue forecast for HCAT next quarter?

Health Catalyst, Inc's revenue is projected to reach 73.97M USD USD in the next quarter. You can view Health Catalyst, Inc's revenue and earnings on the HCAT stock details page.

What is the price target for HCAT?

Based on analyst estimates, the most likely target price for HCAT over the next 12 months is 4.72 USD, with a projected high of 6.81 USD and a projected low of 2.28 USD. To track whether this target is reached within the next year, you can view the HCAT stock price chart on the HCAT stock details page to check the current HCAT stock price, or follow the latest developments related to HCAT on the HCAT Stock News page.

What is the analyst rating for HCAT?

We collected ratings from 24 analysts who have evaluated HCAT stock over the past three months. Most analysts maintain a Buy outlook, and after aggregating all opinions, the overall consensus rating is Buy. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of HCAT stock in 2030?

Based on price forecasts and analyses of Health Catalyst, Inc from Wall Street analysts and major investment banks, HCAT is projected to trade between 3.68 USD and 18.40 USD in 2030.

HCAT stock chart

HCAT stock details

HCAT aksiya narxining o'zgarishi

Oxirgi savdo kunida, HCAT aksiya 1.84 USD narxda yopildi, kun uchun narx o'zgarishi 0.00%.

Aksiya fyucherslari savdosi

Bitget haqida

Dunyodagi birinchi universal birja (UEX) bo'lib, u foydalanuvchilarga nafaqat kriptovalyutalar, balki aksiyalar, ETF, valyutalar, oltin va real aktivlar (RWA) bilan ham savdo qilish imkonini beradi.
Batafsil
NASDAQ/
HCAT stock price forecast